동물 건강 관리 시장 비즈니스 기회, 성장요인, 업계 동향 분석 및 예측(2026-2035년)

The Global Animal Healthcare Market was valued at USD 220.8 billion in 2025 and is estimated to grow at a CAGR of 5.9% to reach USD 399.4 billion by 2035.

Market growth is influenced by the increasing occurrence of animal diseases, including both long-term health conditions and infectious illnesses that require advanced veterinary care. The rising interaction between humans and animals across agricultural settings, residential environments, and urban ecosystems has also elevated the importance of effective animal health management. The animal healthcare market encompasses a broad global industry dedicated to preventing, diagnosing, and treating medical conditions affecting both companion animals and livestock populations. It includes veterinary pharmaceuticals, vaccines, diagnostic solutions, medicated feed additives, medical equipment, and disposable supplies designed to protect animal health and support livestock productivity. In addition, improved disease control helps safeguard public health by reducing the risk of zoonotic disease transmission. The industry is gradually shifting away from generalized treatment methods toward more advanced preventive and targeted healthcare solutions. Increased adoption of biologics and specialized monoclonal antibodies for companion animals is becoming more common, while livestock healthcare is increasingly supported by modern vaccine technologies and herd-level disease prevention strategies. Personalized veterinary medicine is also gaining traction as diagnostic capabilities and biomarker-based testing become more widely available, allowing veterinarians to customize treatments based on species characteristics and specific health conditions. Furthermore, the development of patient-friendly therapeutic options is expanding treatment possibilities beyond conventional medication methods.

The veterinary services segment held a 74.5% share in 2025 and is projected to grow at a CAGR of 6% throughout 2035. This strong market performance is largely driven by increasing disposable income levels and rising demand for professional veterinary care. Growing awareness about animal health and well-being has encouraged more individuals to seek comprehensive veterinary services for their animals. In addition, advancements in veterinary medical technologies have expanded the scope of services available within the sector. A wide range of pet-focused services has become more accessible, supporting higher utilization of veterinary facilities. The integration of modern healthcare technologies and improved service offerings is strengthening the overall veterinary services segment and supporting continued market expansion.

The companion animals segment generated USD 133.1 billion in 2025. This segment is categorized into several groups within the broader companion animal population. Rising global adoption of animals as household companions is a major factor supporting the growth of this segment. A significant portion of households worldwide currently care for animals as companions, contributing to increased demand for veterinary care, medical products, and specialized healthcare services. Higher spending on pet health and wellness is also encouraging the development and introduction of innovative animal healthcare solutions. In addition, growing disposable income levels in emerging economies are enabling more pet owners to invest in advanced healthcare products and veterinary services, further supporting the expansion of the companion animals segment.

North America Animal Healthcare Market held a 38.5% share in 2025. The region maintains a leading position due to its well-established veterinary healthcare infrastructure and widespread adoption of advanced medical solutions for animal care. Strong utilization of innovative therapeutics, vaccines, and parasite control products across both companion animal and livestock populations contributes to regional market growth. North America also benefits from the early implementation of advanced diagnostic technologies and precision veterinary healthcare approaches. The presence of major industry participants with strong research and development capabilities further accelerates innovation within the region. Growing awareness of preventive animal healthcare, along with increasing concern regarding chronic and zoonotic diseases affecting animals, continues to drive demand for advanced veterinary services and premium animal health products.

Key companies operating in the Global Animal Healthcare Market include Zoetis, Merck, Boehringer Ingelheim, Elanco Animal Health, Virbac, Vetoquinol, Ceva Sante Animale, Dechra Pharmaceuticals, IDEXX Laboratories, Phibro Animal Health, Neogen, HIPRA, B. Braun Vet Care (B Braun Melsungen), Symrise, Sklar Surgical Instruments, Medtronic, Endovac Animal Health, Indian Immunologicals, Kyoritsu Seiyaku, and Ourofino Saude Animal. Companies active in the Animal Healthcare Market are implementing several strategic approaches to strengthen their competitive position and expand their global footprint. A key focus area is investment in research and development aimed at introducing innovative veterinary pharmaceuticals, vaccines, and diagnostic technologies. Many organizations are also expanding their product portfolios through strategic partnerships, acquisitions, and collaborations with biotechnology firms and veterinary research institutions. Geographic expansion into emerging markets is another important strategy, as companies seek to capture rising demand for animal health products in developing regions. In addition, firms are enhancing digital capabilities by integrating data-driven diagnostics, tele-veterinary services, and advanced monitoring technologies into their offerings. Companies are also prioritizing sustainable production practices and regulatory compliance to maintain product credibility while supporting long-term growth in the animal healthcare market.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definition
• 1.2 Research approach
• 1.3 Quality commitments
  • 1.3.1 GMI AI policy and data integrity commitment
    • 1.3.1.1 Source consistency protocol
• 1.4 Research trail and confidence scoring
  • 1.4.1 Research trail components
  • 1.4.2 Scoring components
• 1.5 Data collection
  • 1.5.1 Partial list of primary sources
• 1.6 Data mining sources
  • 1.6.1 Paid sources
    • 1.6.1.1 Sources, by region
• 1.7 Base estimates and calculations
  • 1.7.1 Revenue share analysis
  • 1.7.2 Base year calculation
• 1.8 Forecast model
• 1.9 Research transparency addendum
  • 1.9.1 Source attribution framework
  • 1.9.2 Quality assurance metrics
  • 1.9.3 Our commitment to trust

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis
• 2.2 Key market trends
  • 2.2.1 Regional trends
  • 2.2.2 Product trends
  • 2.2.3 Animal type trends
• 2.3 CXO perspectives: Strategic imperatives

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing population of pet animals
    • 3.2.1.2 Increasing support offered by government and public organizations for animal care
    • 3.2.1.3 Growing demand for online veterinary pharmacies
    • 3.2.1.4 Increase in animal healthcare expenditure
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High cost associated with animal health drugs
    • 3.2.2.2 Limited access in rural areas
  • 3.2.3 Market opportunities
    • 3.2.3.1 Expansion of telemedicine and remote veterinary consultation
    • 3.2.3.2 Rising adoption of preventive and wellness-focused animal health solutions
• 3.3 Growth potential analysis
• 3.4 Technology landscape (Driven by Primary Research)
  • 3.4.1 Current technological trends
  • 3.4.2 Emerging technologies
• 3.5 Regulatory landscape (Driven by Primary Research)
  • 3.5.1 North America
  • 3.5.2 Europe
  • 3.5.3 Asia Pacific
  • 3.5.4 Latin America
  • 3.5.5 Middle East and Africa
• 3.6 Reimbursement scenario (Driven by Primary Research)
• 3.7 Venture capitalist scenario in animal health industry
• 3.8 Economic impacts of the animal health industry
• 3.9 Consumer behaviour trends (Driven by Primary Research)
• 3.10 Future market trends (Driven by Primary Research)
• 3.11 Impact of AI and generative AI on the market
• 3.12 Porter's analysis
• 3.13 PESTEL analysis

Chapter 4 Competitive Landscape, 2025

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Key developments
  • 4.6.1 Merger and acquisition
  • 4.6.2 Partnership and collaboration
  • 4.6.3 New product launches
  • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Product, 2022 - 2035 ($ Mn)

• 5.1 Key trends
• 5.2 Pharmaceuticals
  • 5.2.1 Type
    • 5.2.1.1 Drugs
      • 5.2.1.1.1 Antiparasitic
      • 5.2.1.1.2 Anti-inflammatory
      • 5.2.1.1.3 Anti-infectives
      • 5.2.1.1.4 Corticosteroids
      • 5.2.1.1.5 Tranquilizers
      • 5.2.1.1.6 Cardiovascular drugs
      • 5.2.1.1.7 Gastrointestinal drugs
      • 5.2.1.1.8 Other drugs
    • 5.2.1.2 Vaccines
      • 5.2.1.2.1 Modified live vaccines (MLV)
      • 5.2.1.2.2 Killed inactivated vaccines
      • 5.2.1.2.3 Other vaccines
    • 5.2.1.3 Medicated feed additives
      • 5.2.1.3.1 Antibiotics
      • 5.2.1.3.2 Vitamins
      • 5.2.1.3.3 Amino acids
      • 5.2.1.3.4 Enzymes
      • 5.2.1.3.5 Antioxidants
      • 5.2.1.3.6 Prebiotics and probiotics
      • 5.2.1.3.7 Minerals
      • 5.2.1.3.8 Other medicated feed additives
  • 5.2.2 Indication
    • 5.2.2.1 Dermatology
    • 5.2.2.2 Cardiovascular diseases
    • 5.2.2.3 Gastrointestinal diseases
    • 5.2.2.4 Respiratory diseases
    • 5.2.2.5 Other indications
  • 5.2.3 Distribution channel
    • 5.2.3.1 Veterinary hospital pharmacies
    • 5.2.3.2 E-commerce
    • 5.2.3.3 Retail pharmacies
• 5.3 Medical devices
  • 5.3.1 Veterinary diagnostic equipment
  • 5.3.2 Anesthesia equipment
  • 5.3.3 Patient monitoring equipment
  • 5.3.4 Veterinary surgical equipment
  • 5.3.5 Veterinary consumables
  • 5.3.6 Other medical devices
• 5.4 Veterinary services

Chapter 6 Market Estimates and Forecast, By Animal Type, 2022 - 2035 ($ Mn)

• 6.1 Key trends
• 6.2 Companion animals
  • 6.2.1 Dogs
  • 6.2.2 Cats
  • 6.2.3 Horses
  • 6.2.4 Other companion animals
• 6.3 Livestock animals
  • 6.3.1 Poultry
  • 6.3.2 Swine
  • 6.3.3 Cattle
  • 6.3.4 Fish
  • 6.3.5 Other livestock animals

Chapter 7 Market Estimates and Forecast, By Region, 2022 - 2035 ($ Mn)

• 7.1 Key trends
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 UK
  • 7.3.3 France
  • 7.3.4 Spain
  • 7.3.5 Italy
  • 7.3.6 Netherlands
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 India
  • 7.4.3 Japan
  • 7.4.4 Australia
  • 7.4.5 South Korea
• 7.5 Latin America
  • 7.5.1 Brazil
  • 7.5.2 Mexico
  • 7.5.3 Argentina
• 7.6 Middle East and Africa
  • 7.6.1 South Africa
  • 7.6.2 GCC Countries
  • 7.6.3 Israel

Chapter 8 Company Profiles

• 8.1 B. Braun Vet Care (B Braun Melsungen)
• 8.2 Boehringer Ingelheim
• 8.3 Ceva Sante Animale
• 8.4 Dechra Pharmaceuticals
• 8.5 Elanco Animal Health
• 8.6 Endovac Animal Health
• 8.7 HIPRA
• 8.8 IDEXX Laboratories
• 8.9 Merck
• 8.10 Medtronic
• 8.11 Neogen
• 8.12 Sklar Surgical Instruments
• 8.13 Symrise
• 8.14 Vetoquinol
• 8.15 Virbac
• 8.16 Zoetis
• 8.17 Phibro Animal Health
• 8.18 Indian Immunologicals
• 8.19 Kyoritsu Seiyaku
• 8.20 Ourofino Saude Animal